Gå till innehåll

Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal



Persistence. No data.
Bioaccumulation. No data.
Toxicity. No data.
Risk. Cannot be excluded.


Environmental information is missing on fass.se for bimatoprost (2020-09-07). It is voluntary for manufacturers to provide information on environmental impact on fass.se.

Assessment report/scientific discussion

Scientific discussion for Lumigan (bimatoprost) 08/12/2005, EMA 2004

"Risk characterisation calculations have been conducted, showing that the Predicted Environmental Concentration (PEC) of bimatoprost falls below the threshold values for water, soil and grassland. On the background of the calculations, it was considered that the environmental impact of the PEC’s will be insignificant associated with use and disposal of the product by the users." No data are available.

Assessment report for Lumigan London, 7 January 2010 Doc. Ref: EMA/105752/2010

"Based on the data submitted by the MAH (marketing authorisation holder, ed. remark), the use of Lumigan 0.01% is unlikely to represent a risk for the environment when used in the proposed indication and recommended dose." No data are available.

Author: Health and Medical Care Administration, Region Stockholm